Global Gene Editing Market 2020 by Company, Regions, Type and Application, Forecast to 2025
Apr, 2020
|
Report ID: 134569
|
127
|
Information & Communication Technology
Market Overview
The global Gene Editing market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 7.6% in the forecast period of 2020 to 2025 and will expected to reach USD 4050.1 million by 2025, from USD 3021.8 million in 2019.
The Gene Editing market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
Gene Editing market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Gene Editing market has been segmented into:
Zinc finger nucleases (ZFNs)
Transcription Activator-Like Effector-based Nucleases (TALENs)
CRISPR-Cas system
By Application, Gene Editing has been segmented into:
Biotechnology& Pharmaceutical Companies
Academic& Government Research Institutes
Contract Research Organizations
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Gene Editing market presented in the report. This section sheds light on the sales growth of different regional and country-level Gene Editing markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Gene Editing market.
The report offers in-depth assessment of the growth and other aspects of the Gene Editing market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Competitive Landscape and Gene Editing Market Share Analysis
Gene Editing competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Gene Editing sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Gene Editing sales, revenue and market share for each player covered in this report.
The major players covered in Gene Editing are:
Thermo Fisher Scientific
OriGene Technologies
Sangamo BioSciences
Merck
New England Biolabs
Horizo__n Discovery
Editas Medicine
Lonza
Integrated DNA Technologies
Transposagen Biopharmaceuticals
Genscript Biotech
CRISPR Therapeutics
OriGene Technologies
GeneCopoeia
RGen Solutions
Agilent Technologies
Sigma-Aldrich
The global Gene Editing market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 7.6% in the forecast period of 2020 to 2025 and will expected to reach USD 4050.1 million by 2025, from USD 3021.8 million in 2019.
The Gene Editing market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
Gene Editing market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Gene Editing market has been segmented into:
Zinc finger nucleases (ZFNs)
Transcription Activator-Like Effector-based Nucleases (TALENs)
CRISPR-Cas system
By Application, Gene Editing has been segmented into:
Biotechnology& Pharmaceutical Companies
Academic& Government Research Institutes
Contract Research Organizations
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Gene Editing market presented in the report. This section sheds light on the sales growth of different regional and country-level Gene Editing markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Gene Editing market.
The report offers in-depth assessment of the growth and other aspects of the Gene Editing market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Competitive Landscape and Gene Editing Market Share Analysis
Gene Editing competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Gene Editing sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Gene Editing sales, revenue and market share for each player covered in this report.
The major players covered in Gene Editing are:
Thermo Fisher Scientific
OriGene Technologies
Sangamo BioSciences
Merck
New England Biolabs
Horizo__n Discovery
Editas Medicine
Lonza
Integrated DNA Technologies
Transposagen Biopharmaceuticals
Genscript Biotech
CRISPR Therapeutics
OriGene Technologies
GeneCopoeia
RGen Solutions
Agilent Technologies
Sigma-Aldrich
Frequently Asked Questions
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
- By Type
- By Application
- By Region
- By Country
- By Manufacturer
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 Gene Editing Market Overview
1.1 Product Overview and Scope of Gene Editing
1.2 Classification of Gene Editing by Type
1.2.1 Global Gene Editing Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Global Gene Editing Revenue Market Share by Type in 2019
1.2.3 Zinc finger nucleases (ZFNs)
1.2.4 Transcription Activator-Like Effector-based Nucleases (TALENs)
1.2.5 CRISPR-Cas system
1.3 Global Gene Editing Market by Application
1.3.1 Overview: Global Gene Editing Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Biotechnology& Pharmaceutical Companies
1.3.3 Academic& Government Research Institutes
1.3.4 Contract Research Organizations
1.4 Global Gene Editing Market by Regions
1.4.1 Global Gene Editing Market Size by Regions: 2015 VS 2019 VS 2025
1.4.2 Global Market Size of Gene Editing (2015-2025)
1.4.3 North America (USA, Canada and Mexico) Gene Editing Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) Gene Editing Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Gene Editing Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) Gene Editing Status and Prospect (2015-2025)
1.4.7 Middle East& Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Gene Editing Status and Prospect (2015-2025)
2 Company Profiles
2.1 Thermo Fisher Scientific
2.1.1 Thermo Fisher Scientific Details
2.1.2 Thermo Fisher Scientific Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Thermo Fisher Scientific SWOT Analysis
2.1.4 Thermo Fisher Scientific Product and Services
2.1.5 Thermo Fisher Scientific Gene Editing Revenue, Gross Margin and Market Share (2018-2019)
2.2 OriGene Technologies
2.2.1 OriGene Technologies Details
2.2.2 OriGene Technologies Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 OriGene Technologies SWOT Analysis
2.2.4 OriGene Technologies Product and Services
2.2.5 OriGene Technologies Gene Editing Revenue, Gross Margin and Market Share (2018-2019)
2.3 Sangamo BioSciences
2.3.1 Sangamo BioSciences Details
2.3.2 Sangamo BioSciences Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Sangamo BioSciences SWOT Analysis
2.3.4 Sangamo BioSciences Product and Services
2.3.5 Sangamo BioSciences Gene Editing Revenue, Gross Margin and Market Share (2018-2019)
2.4 Merck
2.4.1 Merck Details
2.4.2 Merck Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Merck SWOT Analysis
2.4.4 Merck Product and Services
2.4.5 Merck Gene Editing Revenue, Gross Margin and Market Share (2018-2019)
2.5 New England Biolabs
2.5.1 New England Biolabs Details
2.5.2 New England Biolabs Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 New England Biolabs SWOT Analysis
2.5.4 New England Biolabs Product and Services
2.5.5 New England Biolabs Gene Editing Revenue, Gross Margin and Market Share (2018-2019)
2.6 Horizo__n Discovery
2.6.1 Horizo__n Discovery Details
2.6.2 Horizo__n Discovery Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Horizo__n Discovery SWOT Analysis
2.6.4 Horizo__n Discovery Product and Services
2.6.5 Horizo__n Discovery Gene Editing Revenue, Gross Margin and Market Share (2018-2019)
2.7 Editas Medicine
2.7.1 Editas Medicine Details
2.7.2 Editas Medicine Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Editas Medicine SWOT Analysis
2.7.4 Editas Medicine Product and Services
2.7.5 Editas Medicine Gene Editing Revenue, Gross Margin and Market Share (2018-2019)
2.8 Lonza
2.8.1 Lonza Details
2.8.2 Lonza Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Lonza SWOT Analysis
2.8.4 Lonza Product and Services
2.8.5 Lonza Gene Editing Revenue, Gross Margin and Market Share (2018-2019)
2.9 Integrated DNA Technologies
2.9.1 Integrated DNA Technologies Details
2.9.2 Integrated DNA Technologies Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 Integrated DNA Technologies SWOT Analysis
2.9.4 Integrated DNA Technologies Product and Services
2.9.5 Integrated DNA Technologies Gene Editing Revenue, Gross Margin and Market Share (2018-2019)
2.10 Transposagen Biopharmaceuticals
2.10.1 Transposagen Biopharmaceuticals Details
2.10.2 Transposagen Biopharmaceuticals Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 Transposagen Biopharmaceuticals SWOT Analysis
2.10.4 Transposagen Biopharmaceuticals Product and Services
2.10.5 Transposagen Biopharmaceuticals Gene Editing Revenue, Gross Margin and Market Share (2018-2019)
2.11 Genscript Biotech
2.11.1 Genscript Biotech Details
2.11.2 Genscript Biotech Major Business and Total Revenue (Financial Highlights) Analysis
2.11.3 Genscript Biotech SWOT Analysis
2.11.4 Genscript Biotech Product and Services
2.11.5 Genscript Biotech Gene Editing Revenue, Gross Margin and Market Share (2018-2019)
2.12 CRISPR Therapeutics
2.12.1 CRISPR Therapeutics Details
2.12.2 CRISPR Therapeutics Major Business and Total Revenue (Financial Highlights) Analysis
2.12.3 CRISPR Therapeutics SWOT Analysis
2.12.4 CRISPR Therapeutics Product and Services
2.12.5 CRISPR Therapeutics Gene Editing Revenue, Gross Margin and Market Share (2018-2019)
2.13 OriGene Technologies
2.13.1 OriGene Technologies Details
2.13.2 OriGene Technologies Major Business and Total Revenue (Financial Highlights) Analysis
2.13.3 OriGene Technologies SWOT Analysis
2.13.4 OriGene Technologies Product and Services
2.13.5 OriGene Technologies Gene Editing Revenue, Gross Margin and Market Share (2018-2019)
2.14 GeneCopoeia
2.14.1 GeneCopoeia Details
2.14.2 GeneCopoeia Major Business and Total Revenue (Financial Highlights) Analysis
2.14.3 GeneCopoeia SWOT Analysis
2.14.4 GeneCopoeia Product and Services
2.14.5 GeneCopoeia Gene Editing Revenue, Gross Margin and Market Share (2018-2019)
2.15 RGen Solutions
2.15.1 RGen Solutions Details
2.15.2 RGen Solutions Major Business and Total Revenue (Financial Highlights) Analysis
2.15.3 RGen Solutions SWOT Analysis
2.15.4 RGen Solutions Product and Services
2.15.5 RGen Solutions Gene Editing Revenue, Gross Margin and Market Share (2018-2019)
2.16 Agilent Technologies
2.16.1 Agilent Technologies Details
2.16.2 Agilent Technologies Major Business and Total Revenue (Financial Highlights) Analysis
2.16.3 Agilent Technologies SWOT Analysis
2.16.4 Agilent Technologies Product and Services
2.16.5 Agilent Technologies Gene Editing Revenue, Gross Margin and Market Share (2018-2019)
2.17 Sigma-Aldrich
2.17.1 Sigma-Aldrich Details
2.17.2 Sigma-Aldrich Major Business and Total Revenue (Financial Highlights) Analysis
2.17.3 Sigma-Aldrich SWOT Analysis
2.17.4 Sigma-Aldrich Product and Services
2.17.5 Sigma-Aldrich Gene Editing Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global Gene Editing Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 Gene Editing Players Market Share
3.2.2 Top 10 Gene Editing Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global Gene Editing Revenue and Market Share by Regions
4.2 North America Gene Editing Revenue and Growth Rate (2015-2020)
4.3 Europe Gene Editing Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific Gene Editing Revenue and Growth Rate (2015-2020)
4.5 South America Gene Editing Revenue and Growth Rate (2015-2020)
4.6 Middle East& Africa Gene Editing Revenue and Growth Rate (2015-2020)
5 North America Gene Editing Revenue by Countries
5.1 North America Gene Editing Revenue by Countries (2015-2020)
5.2 USA Gene Editing Revenue and Growth Rate (2015-2020)
5.3 Canada Gene Editing Revenue and Growth Rate (2015-2020)
5.4 Mexico Gene Editing Revenue and Growth Rate (2015-2020)
6 Europe Gene Editing Revenue by Countries
6.1 Europe Gene Editing Revenue by Countries (2015-2020)
6.2 Germany Gene Editing Revenue and Growth Rate (2015-2020)
6.3 UK Gene Editing Revenue and Growth Rate (2015-2020)
6.4 France Gene Editing Revenue and Growth Rate (2015-2020)
6.5 Russia Gene Editing Revenue and Growth Rate (2015-2020)
6.6 Italy Gene Editing Revenue and Growth Rate (2015-2020)
7 Asia-Pacific Gene Editing Revenue by Countries
7.1 Asia-Pacific Gene Editing Revenue by Countries (2015-2020)
7.2 China Gene Editing Revenue and Growth Rate (2015-2020)
7.3 Japan Gene Editing Revenue and Growth Rate (2015-2020)
7.4 Korea Gene Editing Revenue and Growth Rate (2015-2020)
7.5 India Gene Editing Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia Gene Editing Revenue and Growth Rate (2015-2020)
8 South America Gene Editing Revenue by Countries
8.1 South America Gene Editing Revenue by Countries (2015-2020)
8.2 Brazil Gene Editing Revenue and Growth Rate (2015-2020)
8.3 Argentina Gene Editing Revenue and Growth Rate (2015-2020)
9 Middle East& Africa Revenue Gene Editing by Countries
9.1 Middle East& Africa Gene Editing Revenue by Countries (2015-2020)
9.2 Saudi Arabia Gene Editing Revenue and Growth Rate (2015-2020)
9.3 UAE Gene Editing Revenue and Growth Rate (2015-2020)
9.4 Egypt Gene Editing Revenue and Growth Rate (2015-2020)
9.5 South Africa Gene Editing Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global Gene Editing Revenue and Market Share by Type (2015-2020)
10.2 Global Gene Editing Market Forecast by Type (2019-2024)
10.3 Zinc finger nucleases (ZFNs) Revenue Growth Rate (2015-2025)
10.4 Transcription Activator-Like Effector-based Nucleases (TALENs) Revenue Growth Rate (2015-2025)
10.5 CRISPR-Cas system Revenue Growth Rate (2015-2025)
11 Global Gene Editing Market Segment by Application
11.1 Global Gene Editing Revenue Market Share by Application (2015-2020)
11.2 Gene Editing Market Forecast by Application (2019-2024)
11.3 Biotechnology& Pharmaceutical Companies Revenue Growth (2015-2020)
11.4 Academic& Government Research Institutes Revenue Growth (2015-2020)
11.5 Contract Research Organizations Revenue Growth (2015-2020)
12 Global Gene Editing Market Size Forecast (2021-2025)
12.1 Global Gene Editing Market Size Forecast (2021-2025)
12.2 Global Gene Editing Market Forecast by Regions (2021-2025)
12.3 North America Gene Editing Revenue Market Forecast (2021-2025)
12.4 Europe Gene Editing Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific Gene Editing Revenue Market Forecast (2021-2025)
12.6 South America Gene Editing Revenue Market Forecast (2021-2025)
12.7 Middle East& Africa Gene Editing Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US
1 Gene Editing Market Overview
1.1 Product Overview and Scope of Gene Editing
1.2 Classification of Gene Editing by Type
1.2.1 Global Gene Editing Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Global Gene Editing Revenue Market Share by Type in 2019
1.2.3 Zinc finger nucleases (ZFNs)
1.2.4 Transcription Activator-Like Effector-based Nucleases (TALENs)
1.2.5 CRISPR-Cas system
1.3 Global Gene Editing Market by Application
1.3.1 Overview: Global Gene Editing Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Biotechnology& Pharmaceutical Companies
1.3.3 Academic& Government Research Institutes
1.3.4 Contract Research Organizations
1.4 Global Gene Editing Market by Regions
1.4.1 Global Gene Editing Market Size by Regions: 2015 VS 2019 VS 2025
1.4.2 Global Market Size of Gene Editing (2015-2025)
1.4.3 North America (USA, Canada and Mexico) Gene Editing Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) Gene Editing Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Gene Editing Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) Gene Editing Status and Prospect (2015-2025)
1.4.7 Middle East& Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Gene Editing Status and Prospect (2015-2025)
2 Company Profiles
2.1 Thermo Fisher Scientific
2.1.1 Thermo Fisher Scientific Details
2.1.2 Thermo Fisher Scientific Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Thermo Fisher Scientific SWOT Analysis
2.1.4 Thermo Fisher Scientific Product and Services
2.1.5 Thermo Fisher Scientific Gene Editing Revenue, Gross Margin and Market Share (2018-2019)
2.2 OriGene Technologies
2.2.1 OriGene Technologies Details
2.2.2 OriGene Technologies Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 OriGene Technologies SWOT Analysis
2.2.4 OriGene Technologies Product and Services
2.2.5 OriGene Technologies Gene Editing Revenue, Gross Margin and Market Share (2018-2019)
2.3 Sangamo BioSciences
2.3.1 Sangamo BioSciences Details
2.3.2 Sangamo BioSciences Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Sangamo BioSciences SWOT Analysis
2.3.4 Sangamo BioSciences Product and Services
2.3.5 Sangamo BioSciences Gene Editing Revenue, Gross Margin and Market Share (2018-2019)
2.4 Merck
2.4.1 Merck Details
2.4.2 Merck Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Merck SWOT Analysis
2.4.4 Merck Product and Services
2.4.5 Merck Gene Editing Revenue, Gross Margin and Market Share (2018-2019)
2.5 New England Biolabs
2.5.1 New England Biolabs Details
2.5.2 New England Biolabs Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 New England Biolabs SWOT Analysis
2.5.4 New England Biolabs Product and Services
2.5.5 New England Biolabs Gene Editing Revenue, Gross Margin and Market Share (2018-2019)
2.6 Horizo__n Discovery
2.6.1 Horizo__n Discovery Details
2.6.2 Horizo__n Discovery Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Horizo__n Discovery SWOT Analysis
2.6.4 Horizo__n Discovery Product and Services
2.6.5 Horizo__n Discovery Gene Editing Revenue, Gross Margin and Market Share (2018-2019)
2.7 Editas Medicine
2.7.1 Editas Medicine Details
2.7.2 Editas Medicine Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Editas Medicine SWOT Analysis
2.7.4 Editas Medicine Product and Services
2.7.5 Editas Medicine Gene Editing Revenue, Gross Margin and Market Share (2018-2019)
2.8 Lonza
2.8.1 Lonza Details
2.8.2 Lonza Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Lonza SWOT Analysis
2.8.4 Lonza Product and Services
2.8.5 Lonza Gene Editing Revenue, Gross Margin and Market Share (2018-2019)
2.9 Integrated DNA Technologies
2.9.1 Integrated DNA Technologies Details
2.9.2 Integrated DNA Technologies Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 Integrated DNA Technologies SWOT Analysis
2.9.4 Integrated DNA Technologies Product and Services
2.9.5 Integrated DNA Technologies Gene Editing Revenue, Gross Margin and Market Share (2018-2019)
2.10 Transposagen Biopharmaceuticals
2.10.1 Transposagen Biopharmaceuticals Details
2.10.2 Transposagen Biopharmaceuticals Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 Transposagen Biopharmaceuticals SWOT Analysis
2.10.4 Transposagen Biopharmaceuticals Product and Services
2.10.5 Transposagen Biopharmaceuticals Gene Editing Revenue, Gross Margin and Market Share (2018-2019)
2.11 Genscript Biotech
2.11.1 Genscript Biotech Details
2.11.2 Genscript Biotech Major Business and Total Revenue (Financial Highlights) Analysis
2.11.3 Genscript Biotech SWOT Analysis
2.11.4 Genscript Biotech Product and Services
2.11.5 Genscript Biotech Gene Editing Revenue, Gross Margin and Market Share (2018-2019)
2.12 CRISPR Therapeutics
2.12.1 CRISPR Therapeutics Details
2.12.2 CRISPR Therapeutics Major Business and Total Revenue (Financial Highlights) Analysis
2.12.3 CRISPR Therapeutics SWOT Analysis
2.12.4 CRISPR Therapeutics Product and Services
2.12.5 CRISPR Therapeutics Gene Editing Revenue, Gross Margin and Market Share (2018-2019)
2.13 OriGene Technologies
2.13.1 OriGene Technologies Details
2.13.2 OriGene Technologies Major Business and Total Revenue (Financial Highlights) Analysis
2.13.3 OriGene Technologies SWOT Analysis
2.13.4 OriGene Technologies Product and Services
2.13.5 OriGene Technologies Gene Editing Revenue, Gross Margin and Market Share (2018-2019)
2.14 GeneCopoeia
2.14.1 GeneCopoeia Details
2.14.2 GeneCopoeia Major Business and Total Revenue (Financial Highlights) Analysis
2.14.3 GeneCopoeia SWOT Analysis
2.14.4 GeneCopoeia Product and Services
2.14.5 GeneCopoeia Gene Editing Revenue, Gross Margin and Market Share (2018-2019)
2.15 RGen Solutions
2.15.1 RGen Solutions Details
2.15.2 RGen Solutions Major Business and Total Revenue (Financial Highlights) Analysis
2.15.3 RGen Solutions SWOT Analysis
2.15.4 RGen Solutions Product and Services
2.15.5 RGen Solutions Gene Editing Revenue, Gross Margin and Market Share (2018-2019)
2.16 Agilent Technologies
2.16.1 Agilent Technologies Details
2.16.2 Agilent Technologies Major Business and Total Revenue (Financial Highlights) Analysis
2.16.3 Agilent Technologies SWOT Analysis
2.16.4 Agilent Technologies Product and Services
2.16.5 Agilent Technologies Gene Editing Revenue, Gross Margin and Market Share (2018-2019)
2.17 Sigma-Aldrich
2.17.1 Sigma-Aldrich Details
2.17.2 Sigma-Aldrich Major Business and Total Revenue (Financial Highlights) Analysis
2.17.3 Sigma-Aldrich SWOT Analysis
2.17.4 Sigma-Aldrich Product and Services
2.17.5 Sigma-Aldrich Gene Editing Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global Gene Editing Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 Gene Editing Players Market Share
3.2.2 Top 10 Gene Editing Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global Gene Editing Revenue and Market Share by Regions
4.2 North America Gene Editing Revenue and Growth Rate (2015-2020)
4.3 Europe Gene Editing Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific Gene Editing Revenue and Growth Rate (2015-2020)
4.5 South America Gene Editing Revenue and Growth Rate (2015-2020)
4.6 Middle East& Africa Gene Editing Revenue and Growth Rate (2015-2020)
5 North America Gene Editing Revenue by Countries
5.1 North America Gene Editing Revenue by Countries (2015-2020)
5.2 USA Gene Editing Revenue and Growth Rate (2015-2020)
5.3 Canada Gene Editing Revenue and Growth Rate (2015-2020)
5.4 Mexico Gene Editing Revenue and Growth Rate (2015-2020)
6 Europe Gene Editing Revenue by Countries
6.1 Europe Gene Editing Revenue by Countries (2015-2020)
6.2 Germany Gene Editing Revenue and Growth Rate (2015-2020)
6.3 UK Gene Editing Revenue and Growth Rate (2015-2020)
6.4 France Gene Editing Revenue and Growth Rate (2015-2020)
6.5 Russia Gene Editing Revenue and Growth Rate (2015-2020)
6.6 Italy Gene Editing Revenue and Growth Rate (2015-2020)
7 Asia-Pacific Gene Editing Revenue by Countries
7.1 Asia-Pacific Gene Editing Revenue by Countries (2015-2020)
7.2 China Gene Editing Revenue and Growth Rate (2015-2020)
7.3 Japan Gene Editing Revenue and Growth Rate (2015-2020)
7.4 Korea Gene Editing Revenue and Growth Rate (2015-2020)
7.5 India Gene Editing Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia Gene Editing Revenue and Growth Rate (2015-2020)
8 South America Gene Editing Revenue by Countries
8.1 South America Gene Editing Revenue by Countries (2015-2020)
8.2 Brazil Gene Editing Revenue and Growth Rate (2015-2020)
8.3 Argentina Gene Editing Revenue and Growth Rate (2015-2020)
9 Middle East& Africa Revenue Gene Editing by Countries
9.1 Middle East& Africa Gene Editing Revenue by Countries (2015-2020)
9.2 Saudi Arabia Gene Editing Revenue and Growth Rate (2015-2020)
9.3 UAE Gene Editing Revenue and Growth Rate (2015-2020)
9.4 Egypt Gene Editing Revenue and Growth Rate (2015-2020)
9.5 South Africa Gene Editing Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global Gene Editing Revenue and Market Share by Type (2015-2020)
10.2 Global Gene Editing Market Forecast by Type (2019-2024)
10.3 Zinc finger nucleases (ZFNs) Revenue Growth Rate (2015-2025)
10.4 Transcription Activator-Like Effector-based Nucleases (TALENs) Revenue Growth Rate (2015-2025)
10.5 CRISPR-Cas system Revenue Growth Rate (2015-2025)
11 Global Gene Editing Market Segment by Application
11.1 Global Gene Editing Revenue Market Share by Application (2015-2020)
11.2 Gene Editing Market Forecast by Application (2019-2024)
11.3 Biotechnology& Pharmaceutical Companies Revenue Growth (2015-2020)
11.4 Academic& Government Research Institutes Revenue Growth (2015-2020)
11.5 Contract Research Organizations Revenue Growth (2015-2020)
12 Global Gene Editing Market Size Forecast (2021-2025)
12.1 Global Gene Editing Market Size Forecast (2021-2025)
12.2 Global Gene Editing Market Forecast by Regions (2021-2025)
12.3 North America Gene Editing Revenue Market Forecast (2021-2025)
12.4 Europe Gene Editing Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific Gene Editing Revenue Market Forecast (2021-2025)
12.6 South America Gene Editing Revenue Market Forecast (2021-2025)
12.7 Middle East& Africa Gene Editing Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US
List of Tables
Table 1. Global Gene Editing Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Gene Editing by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Gene Editing Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Global Market Gene Editing Revenue (Million USD) Comparison by Regions 2015-2025
Table 5. Thermo Fisher Scientific Corporate Information, Location and Competitors
Table 6. Thermo Fisher Scientific Gene Editing Major Business
Table 7. Thermo Fisher Scientific Gene Editing Total Revenue (USD Million) (2017-2018)
Table 8. Thermo Fisher Scientific SWOT Analysis
Table 9. Thermo Fisher Scientific Gene Editing Product and Solutions
Table 10. Thermo Fisher Scientific Gene Editing Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 11. OriGene Technologies Corporate Information, Location and Competitors
Table 12. OriGene Technologies Gene Editing Major Business
Table 13. OriGene Technologies Gene Editing Total Revenue (USD Million) (2018-2019)
Table 14. OriGene Technologies SWOT Analysis
Table 15. OriGene Technologies Gene Editing Product and Solutions
Table 16. OriGene Technologies Gene Editing Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 17. Sangamo BioSciences Corporate Information, Location and Competitors
Table 18. Sangamo BioSciences Gene Editing Major Business
Table 19. Sangamo BioSciences Gene Editing Total Revenue (USD Million) (2017-2018)
Table 20. Sangamo BioSciences SWOT Analysis
Table 21. Sangamo BioSciences Gene Editing Product and Solutions
Table 22. Sangamo BioSciences Gene Editing Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 23. Merck Corporate Information, Location and Competitors
Table 24. Merck Gene Editing Major Business
Table 25. Merck Gene Editing Total Revenue (USD Million) (2017-2018)
Table 26. Merck SWOT Analysis
Table 27. Merck Gene Editing Product and Solutions
Table 28. Merck Gene Editing Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 29. New England Biolabs Corporate Information, Location and Competitors
Table 30. New England Biolabs Gene Editing Major Business
Table 31. New England Biolabs Gene Editing Total Revenue (USD Million) (2017-2018)
Table 32. New England Biolabs SWOT Analysis
Table 33. New England Biolabs Gene Editing Product and Solutions
Table 34. New England Biolabs Gene Editing Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 35. Horizo__n Discovery Corporate Information, Location and Competitors
Table 36. Horizo__n Discovery Gene Editing Major Business
Table 37. Horizo__n Discovery Gene Editing Total Revenue (USD Million) (2017-2018)
Table 38. Horizo__n Discovery SWOT Analysis
Table 39. Horizo__n Discovery Gene Editing Product and Solutions
Table 40. Horizo__n Discovery Gene Editing Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 41. Editas Medicine Corporate Information, Location and Competitors
Table 42. Editas Medicine Gene Editing Major Business
Table 43. Editas Medicine Gene Editing Total Revenue (USD Million) (2017-2018)
Table 44. Editas Medicine SWOT Analysis
Table 45. Editas Medicine Gene Editing Product and Solutions
Table 46. Editas Medicine Gene Editing Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 47. Lonza Corporate Information, Location and Competitors
Table 48. Lonza Gene Editing Major Business
Table 49. Lonza Gene Editing Total Revenue (USD Million) (2017-2018)
Table 50. Lonza SWOT Analysis
Table 51. Lonza Gene Editing Product and Solutions
Table 52. Lonza Gene Editing Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 53. Integrated DNA Technologies Corporate Information, Location and Competitors
Table 54. Integrated DNA Technologies Gene Editing Major Business
Table 55. Integrated DNA Technologies Gene Editing Total Revenue (USD Million) (2017-2018)
Table 56. Integrated DNA Technologies SWOT Analysis
Table 57. Integrated DNA Technologies Gene Editing Product and Solutions
Table 58. Integrated DNA Technologies Gene Editing Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 59. Transposagen Biopharmaceuticals Corporate Information, Location and Competitors
Table 60. Transposagen Biopharmaceuticals Gene Editing Major Business
Table 61. Transposagen Biopharmaceuticals Gene Editing Total Revenue (USD Million) (2017-2018)
Table 62. Transposagen Biopharmaceuticals SWOT Analysis
Table 63. Transposagen Biopharmaceuticals Gene Editing Product and Solutions
Table 64. Transposagen Biopharmaceuticals Gene Editing Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 65. Genscript Biotech Corporate Information, Location and Competitors
Table 66. Genscript Biotech Gene Editing Major Business
Table 67. Genscript Biotech Gene Editing Total Revenue (USD Million) (2017-2018)
Table 68. Genscript Biotech SWOT Analysis
Table 69. Genscript Biotech Gene Editing Product and Solutions
Table 70. Genscript Biotech Gene Editing Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 71. CRISPR Therapeutics Corporate Information, Location and Competitors
Table 72. CRISPR Therapeutics Gene Editing Major Business
Table 73. CRISPR Therapeutics Gene Editing Total Revenue (USD Million) (2017-2018)
Table 74. CRISPR Therapeutics SWOT Analysis
Table 75. CRISPR Therapeutics Gene Editing Product and Solutions
Table 76. CRISPR Therapeutics Gene Editing Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 77. OriGene Technologies Corporate Information, Location and Competitors
Table 78. OriGene Technologies Gene Editing Major Business
Table 79. OriGene Technologies Gene Editing Total Revenue (USD Million) (2017-2018)
Table 80. OriGene Technologies SWOT Analysis
Table 81. OriGene Technologies Gene Editing Product and Solutions
Table 82. OriGene Technologies Gene Editing Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 83. GeneCopoeia Corporate Information, Location and Competitors
Table 84. GeneCopoeia Gene Editing Major Business
Table 85. GeneCopoeia Gene Editing Total Revenue (USD Million) (2017-2018)
Table 86. GeneCopoeia SWOT Analysis
Table 87. GeneCopoeia Gene Editing Product and Solutions
Table 88. GeneCopoeia Gene Editing Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 89. RGen Solutions Corporate Information, Location and Competitors
Table 90. RGen Solutions Gene Editing Major Business
Table 91. RGen Solutions Gene Editing Total Revenue (USD Million) (2017-2018)
Table 92. RGen Solutions SWOT Analysis
Table 93. RGen Solutions Gene Editing Product and Solutions
Table 94. RGen Solutions Gene Editing Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 95. Agilent Technologies Corporate Information, Location and Competitors
Table 96. Agilent Technologies Gene Editing Major Business
Table 97. Agilent Technologies Gene Editing Total Revenue (USD Million) (2017-2018)
Table 98. Agilent Technologies SWOT Analysis
Table 99. Agilent Technologies Gene Editing Product and Solutions
Table 100. Agilent Technologies Gene Editing Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 101. Sigma-Aldrich Corporate Information, Location and Competitors
Table 102. Sigma-Aldrich Gene Editing Major Business
Table 103. Sigma-Aldrich Gene Editing Total Revenue (USD Million) (2017-2018)
Table 104. Sigma-Aldrich SWOT Analysis
Table 105. Sigma-Aldrich Gene Editing Product and Solutions
Table 106. Sigma-Aldrich Gene Editing Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 107. Global Gene Editing Revenue (Million USD) by Players (2015-2020)
Table 108. Global Gene Editing Revenue Share by Players (2015-2020)
Table 109. Global Gene Editing Revenue (Million USD) by Regions (2015-2020)
Table 110. Global Gene Editing Revenue Market Share by Regions (2015-2020)
Table 111. North America Gene Editing Revenue by Countries (2015-2020)
Table 112. North America Gene Editing Revenue Market Share by Countries (2015-2020)
Table 113. Europe Gene Editing Revenue (Million USD) by Countries (2015-2020)
Table 114. Asia-Pacific Gene Editing Revenue (Million USD) by Countries (2015-2020)
Table 115. South America Gene Editing Revenue by Countries (2015-2020)
Table 116. South America Gene Editing Revenue Market Share by Countries (2015-2020)
Table 117. Middle East and Africa Gene Editing Revenue (Million USD) by Countries (2015-2020)
Table 118. Middle East and Africa Gene Editing Revenue Market Share by Countries (2015-2020)
Table 119. Global Gene Editing Revenue (Million USD) by Type (2015-2020)
Table 120. Global Gene Editing Revenue Share by Type (2015-2020)
Table 121. Global Gene Editing Revenue Forecast by Type (2021-2025)
Table 122. Global Gene Editing Revenue by Application (2015-2020)
Table 123. Global Gene Editing Revenue Share by Application (2015-2020)
Table 124. Global Gene Editing Revenue Forecast by Application (2021-2025)
Table 125. Global Gene Editing Revenue (Million USD) Forecast by Regions (2021-2025)
List of Figures
Figure 1. Gene Editing Picture
Figure 2. Global Gene Editing Revenue Market Share by Type in 2019
Figure 3. Zinc finger nucleases (ZFNs) Picture
Figure 4. Transcription Activator-Like Effector-based Nucleases (TALENs) Picture
Figure 5. CRISPR-Cas system Picture
Figure 6. Gene Editing Revenue Market Share by Application in 2019
Figure 7. Biotechnology& Pharmaceutical Companies Picture
Figure 8. Academic& Government Research Institutes Picture
Figure 9. Contract Research Organizations Picture
Figure 10. Global Gene Editing Revenue (USD Million) and Growth Rate (2015-2025)
Figure 11. North America Gene Editing Revenue (Million USD) and Growth Rate (2015-2025)
Figure 12. Europe Gene Editing Revenue (Million USD) and Growth Rate (2015-2025)
Figure 13. Asia-Pacific Gene Editing Revenue (Million USD) and Growth Rate (2015-2025)
Figure 14. South America Gene Editing Revenue (Million USD) and Growth Rate (2015-2025)
Figure 15. Middle East and Africa Gene Editing Revenue (Million USD) and Growth Rate (2015-2025)
Figure 16. Global Gene Editing Revenue (Million USD) and Growth Rate (2015-2025)
Figure 17. Global Gene Editing Revenue Share by Players in 2019
Figure 18. Global Top 5 Players Gene Editing Revenue Market Share in 2019
Figure 19. Global Top 10 Players Gene Editing Revenue Market Share in 2019
Figure 20. Key Players Market Share Trend
Figure 21. Global Gene Editing Revenue (Million USD) and Growth Rate (%) (2015-2020)
Figure 22. Global Gene Editing Revenue Market Share by Regions (2015-2020)
Figure 23. Global Gene Editing Revenue Market Share by Regions in 2018
Figure 24. North America Gene Editing Revenue and Growth Rate (2015-2020)
Figure 25. Europe Gene Editing Revenue and Growth Rate (2015-2020)
Figure 26. Asia-Pacific Gene Editing Revenue and Growth Rate (2015-2020)
Figure 27. South America Gene Editing Revenue and Growth Rate (2015-2020)
Figure 28. Middle East and Africa Gene Editing Revenue and Growth Rate (2015-2020)
Figure 29. North America Gene Editing Revenue Market Share by Countries (2015-2020)
Figure 30. North America Gene Editing Revenue Market Share by Countries in 2019
Figure 31. USA Gene Editing Revenue and Growth Rate (2015-2020)
Figure 32. Canada Gene Editing Revenue and Growth Rate (2015-2020)
Figure 33. Mexico Gene Editing Revenue and Growth Rate (2015-2020)
Figure 34. Europe Gene Editing Revenue Market Share by Countries (2015-2020)
Figure 35. Europe Gene Editing Revenue Market Share by Countries in 2019
Figure 36. Germany Gene Editing Revenue and Growth Rate (2015-2020)
Figure 37. UK Gene Editing Revenue and Growth Rate (2015-2020)
Figure 38. France Gene Editing Revenue and Growth Rate (2015-2020)
Figure 39. Russia Gene Editing Revenue and Growth Rate (2015-2020)
Figure 40. Italy Gene Editing Revenue and Growth Rate (2015-2020)
Figure 41. Asia-Pacific Gene Editing Revenue Market Share by Countries (2015-2020)
Figure 42. Asia-Pacific Gene Editing Revenue Market Share by Countries in 2019
Figure 43. China Gene Editing Revenue and Growth Rate (2015-2020)
Figure 44. Japan Gene Editing Revenue and Growth Rate (2015-2020)
Figure 45. Korea Gene Editing Revenue and Growth Rate (2015-2020)
Figure 46. India Gene Editing Revenue and Growth Rate (2015-2020)
Figure 47. Southeast Asia Gene Editing Revenue and Growth Rate (2015-2020)
Figure 48. South America Gene Editing Revenue Market Share by Countries (2015-2020)
Figure 49. South America Gene Editing Revenue Market Share by Countries in 2019
Figure 50. Brazil Gene Editing Revenue and Growth Rate (2015-2020)
Figure 51. Argentina Gene Editing Revenue and Growth Rate (2015-2020)
Figure 52. Middle East and Africa Gene Editing Revenue Market Share by Countries (2015-2020)
Figure 53. Middle East and Africa Gene Editing Revenue Market Share by Countries in 2019
Figure 54. Saudi Arabia Gene Editing Revenue and Growth Rate (2015-2020)
Figure 55. UAE Gene Editing Revenue and Growth Rate (2015-2020)
Figure 56. Egypt Gene Editing Revenue and Growth Rate (2015-2020)
Figure 57. South Africa Gene Editing Revenue and Growth Rate (2015-2020)
Figure 58. Global Gene Editing Revenue Share by Type (2015-2020)
Figure 59. Global Gene Editing Revenue Share by Type in 2019
Figure 60. Global Gene Editing Market Share Forecast by Type (2021-2025)
Figure 61. Global Zinc finger nucleases (ZFNs) Revenue Growth Rate (2015-2020)
Figure 62. Global Transcription Activator-Like Effector-based Nucleases (TALENs) Revenue Growth Rate (2015-2020)
Figure 63. Global CRISPR-Cas system Revenue Growth Rate (2015-2020)
Figure 64. Global Gene Editing Revenue Share by Application (2015-2020)
Figure 65. Global Gene Editing Revenue Share by Application in 2019
Figure 66. Global Gene Editing Market Share Forecast by Application (2021-2025)
Figure 67. Global Biotechnology& Pharmaceutical Companies Revenue Growth Rate (2015-2020)
Figure 68. Global Academic& Government Research Institutes Revenue Growth Rate (2015-2020)
Figure 69. Global Contract Research Organizations Revenue Growth Rate (2015-2020)
Figure 70. Global Gene Editing Revenue (Million USD) and Growth Rate Forecast (2021-2025)
Figure 71. Global Gene Editing Revenue (Million USD) Forecast by Regions (2021-2025)
Figure 72. Global Gene Editing Revenue Market Share Forecast by Regions (2021-2025)
Figure 73. North America Gene Editing Revenue Market Forecast (2021-2025)
Figure 74. Europe Gene Editing Revenue Market Forecast (2021-2025)
Figure 75. Asia-Pacific Gene Editing Revenue Market Forecast (2021-2025)
Figure 76. South America Gene Editing Revenue Market Forecast (2021-2025)
Figure 77. Middle East and Africa Gene Editing Revenue Market Forecast (2021-2025)
Figure 78. Sales Channel: Direct Channel vs Indirect Channel
Table 1. Global Gene Editing Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Gene Editing by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Gene Editing Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Global Market Gene Editing Revenue (Million USD) Comparison by Regions 2015-2025
Table 5. Thermo Fisher Scientific Corporate Information, Location and Competitors
Table 6. Thermo Fisher Scientific Gene Editing Major Business
Table 7. Thermo Fisher Scientific Gene Editing Total Revenue (USD Million) (2017-2018)
Table 8. Thermo Fisher Scientific SWOT Analysis
Table 9. Thermo Fisher Scientific Gene Editing Product and Solutions
Table 10. Thermo Fisher Scientific Gene Editing Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 11. OriGene Technologies Corporate Information, Location and Competitors
Table 12. OriGene Technologies Gene Editing Major Business
Table 13. OriGene Technologies Gene Editing Total Revenue (USD Million) (2018-2019)
Table 14. OriGene Technologies SWOT Analysis
Table 15. OriGene Technologies Gene Editing Product and Solutions
Table 16. OriGene Technologies Gene Editing Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 17. Sangamo BioSciences Corporate Information, Location and Competitors
Table 18. Sangamo BioSciences Gene Editing Major Business
Table 19. Sangamo BioSciences Gene Editing Total Revenue (USD Million) (2017-2018)
Table 20. Sangamo BioSciences SWOT Analysis
Table 21. Sangamo BioSciences Gene Editing Product and Solutions
Table 22. Sangamo BioSciences Gene Editing Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 23. Merck Corporate Information, Location and Competitors
Table 24. Merck Gene Editing Major Business
Table 25. Merck Gene Editing Total Revenue (USD Million) (2017-2018)
Table 26. Merck SWOT Analysis
Table 27. Merck Gene Editing Product and Solutions
Table 28. Merck Gene Editing Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 29. New England Biolabs Corporate Information, Location and Competitors
Table 30. New England Biolabs Gene Editing Major Business
Table 31. New England Biolabs Gene Editing Total Revenue (USD Million) (2017-2018)
Table 32. New England Biolabs SWOT Analysis
Table 33. New England Biolabs Gene Editing Product and Solutions
Table 34. New England Biolabs Gene Editing Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 35. Horizo__n Discovery Corporate Information, Location and Competitors
Table 36. Horizo__n Discovery Gene Editing Major Business
Table 37. Horizo__n Discovery Gene Editing Total Revenue (USD Million) (2017-2018)
Table 38. Horizo__n Discovery SWOT Analysis
Table 39. Horizo__n Discovery Gene Editing Product and Solutions
Table 40. Horizo__n Discovery Gene Editing Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 41. Editas Medicine Corporate Information, Location and Competitors
Table 42. Editas Medicine Gene Editing Major Business
Table 43. Editas Medicine Gene Editing Total Revenue (USD Million) (2017-2018)
Table 44. Editas Medicine SWOT Analysis
Table 45. Editas Medicine Gene Editing Product and Solutions
Table 46. Editas Medicine Gene Editing Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 47. Lonza Corporate Information, Location and Competitors
Table 48. Lonza Gene Editing Major Business
Table 49. Lonza Gene Editing Total Revenue (USD Million) (2017-2018)
Table 50. Lonza SWOT Analysis
Table 51. Lonza Gene Editing Product and Solutions
Table 52. Lonza Gene Editing Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 53. Integrated DNA Technologies Corporate Information, Location and Competitors
Table 54. Integrated DNA Technologies Gene Editing Major Business
Table 55. Integrated DNA Technologies Gene Editing Total Revenue (USD Million) (2017-2018)
Table 56. Integrated DNA Technologies SWOT Analysis
Table 57. Integrated DNA Technologies Gene Editing Product and Solutions
Table 58. Integrated DNA Technologies Gene Editing Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 59. Transposagen Biopharmaceuticals Corporate Information, Location and Competitors
Table 60. Transposagen Biopharmaceuticals Gene Editing Major Business
Table 61. Transposagen Biopharmaceuticals Gene Editing Total Revenue (USD Million) (2017-2018)
Table 62. Transposagen Biopharmaceuticals SWOT Analysis
Table 63. Transposagen Biopharmaceuticals Gene Editing Product and Solutions
Table 64. Transposagen Biopharmaceuticals Gene Editing Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 65. Genscript Biotech Corporate Information, Location and Competitors
Table 66. Genscript Biotech Gene Editing Major Business
Table 67. Genscript Biotech Gene Editing Total Revenue (USD Million) (2017-2018)
Table 68. Genscript Biotech SWOT Analysis
Table 69. Genscript Biotech Gene Editing Product and Solutions
Table 70. Genscript Biotech Gene Editing Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 71. CRISPR Therapeutics Corporate Information, Location and Competitors
Table 72. CRISPR Therapeutics Gene Editing Major Business
Table 73. CRISPR Therapeutics Gene Editing Total Revenue (USD Million) (2017-2018)
Table 74. CRISPR Therapeutics SWOT Analysis
Table 75. CRISPR Therapeutics Gene Editing Product and Solutions
Table 76. CRISPR Therapeutics Gene Editing Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 77. OriGene Technologies Corporate Information, Location and Competitors
Table 78. OriGene Technologies Gene Editing Major Business
Table 79. OriGene Technologies Gene Editing Total Revenue (USD Million) (2017-2018)
Table 80. OriGene Technologies SWOT Analysis
Table 81. OriGene Technologies Gene Editing Product and Solutions
Table 82. OriGene Technologies Gene Editing Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 83. GeneCopoeia Corporate Information, Location and Competitors
Table 84. GeneCopoeia Gene Editing Major Business
Table 85. GeneCopoeia Gene Editing Total Revenue (USD Million) (2017-2018)
Table 86. GeneCopoeia SWOT Analysis
Table 87. GeneCopoeia Gene Editing Product and Solutions
Table 88. GeneCopoeia Gene Editing Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 89. RGen Solutions Corporate Information, Location and Competitors
Table 90. RGen Solutions Gene Editing Major Business
Table 91. RGen Solutions Gene Editing Total Revenue (USD Million) (2017-2018)
Table 92. RGen Solutions SWOT Analysis
Table 93. RGen Solutions Gene Editing Product and Solutions
Table 94. RGen Solutions Gene Editing Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 95. Agilent Technologies Corporate Information, Location and Competitors
Table 96. Agilent Technologies Gene Editing Major Business
Table 97. Agilent Technologies Gene Editing Total Revenue (USD Million) (2017-2018)
Table 98. Agilent Technologies SWOT Analysis
Table 99. Agilent Technologies Gene Editing Product and Solutions
Table 100. Agilent Technologies Gene Editing Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 101. Sigma-Aldrich Corporate Information, Location and Competitors
Table 102. Sigma-Aldrich Gene Editing Major Business
Table 103. Sigma-Aldrich Gene Editing Total Revenue (USD Million) (2017-2018)
Table 104. Sigma-Aldrich SWOT Analysis
Table 105. Sigma-Aldrich Gene Editing Product and Solutions
Table 106. Sigma-Aldrich Gene Editing Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 107. Global Gene Editing Revenue (Million USD) by Players (2015-2020)
Table 108. Global Gene Editing Revenue Share by Players (2015-2020)
Table 109. Global Gene Editing Revenue (Million USD) by Regions (2015-2020)
Table 110. Global Gene Editing Revenue Market Share by Regions (2015-2020)
Table 111. North America Gene Editing Revenue by Countries (2015-2020)
Table 112. North America Gene Editing Revenue Market Share by Countries (2015-2020)
Table 113. Europe Gene Editing Revenue (Million USD) by Countries (2015-2020)
Table 114. Asia-Pacific Gene Editing Revenue (Million USD) by Countries (2015-2020)
Table 115. South America Gene Editing Revenue by Countries (2015-2020)
Table 116. South America Gene Editing Revenue Market Share by Countries (2015-2020)
Table 117. Middle East and Africa Gene Editing Revenue (Million USD) by Countries (2015-2020)
Table 118. Middle East and Africa Gene Editing Revenue Market Share by Countries (2015-2020)
Table 119. Global Gene Editing Revenue (Million USD) by Type (2015-2020)
Table 120. Global Gene Editing Revenue Share by Type (2015-2020)
Table 121. Global Gene Editing Revenue Forecast by Type (2021-2025)
Table 122. Global Gene Editing Revenue by Application (2015-2020)
Table 123. Global Gene Editing Revenue Share by Application (2015-2020)
Table 124. Global Gene Editing Revenue Forecast by Application (2021-2025)
Table 125. Global Gene Editing Revenue (Million USD) Forecast by Regions (2021-2025)
List of Figures
Figure 1. Gene Editing Picture
Figure 2. Global Gene Editing Revenue Market Share by Type in 2019
Figure 3. Zinc finger nucleases (ZFNs) Picture
Figure 4. Transcription Activator-Like Effector-based Nucleases (TALENs) Picture
Figure 5. CRISPR-Cas system Picture
Figure 6. Gene Editing Revenue Market Share by Application in 2019
Figure 7. Biotechnology& Pharmaceutical Companies Picture
Figure 8. Academic& Government Research Institutes Picture
Figure 9. Contract Research Organizations Picture
Figure 10. Global Gene Editing Revenue (USD Million) and Growth Rate (2015-2025)
Figure 11. North America Gene Editing Revenue (Million USD) and Growth Rate (2015-2025)
Figure 12. Europe Gene Editing Revenue (Million USD) and Growth Rate (2015-2025)
Figure 13. Asia-Pacific Gene Editing Revenue (Million USD) and Growth Rate (2015-2025)
Figure 14. South America Gene Editing Revenue (Million USD) and Growth Rate (2015-2025)
Figure 15. Middle East and Africa Gene Editing Revenue (Million USD) and Growth Rate (2015-2025)
Figure 16. Global Gene Editing Revenue (Million USD) and Growth Rate (2015-2025)
Figure 17. Global Gene Editing Revenue Share by Players in 2019
Figure 18. Global Top 5 Players Gene Editing Revenue Market Share in 2019
Figure 19. Global Top 10 Players Gene Editing Revenue Market Share in 2019
Figure 20. Key Players Market Share Trend
Figure 21. Global Gene Editing Revenue (Million USD) and Growth Rate (%) (2015-2020)
Figure 22. Global Gene Editing Revenue Market Share by Regions (2015-2020)
Figure 23. Global Gene Editing Revenue Market Share by Regions in 2018
Figure 24. North America Gene Editing Revenue and Growth Rate (2015-2020)
Figure 25. Europe Gene Editing Revenue and Growth Rate (2015-2020)
Figure 26. Asia-Pacific Gene Editing Revenue and Growth Rate (2015-2020)
Figure 27. South America Gene Editing Revenue and Growth Rate (2015-2020)
Figure 28. Middle East and Africa Gene Editing Revenue and Growth Rate (2015-2020)
Figure 29. North America Gene Editing Revenue Market Share by Countries (2015-2020)
Figure 30. North America Gene Editing Revenue Market Share by Countries in 2019
Figure 31. USA Gene Editing Revenue and Growth Rate (2015-2020)
Figure 32. Canada Gene Editing Revenue and Growth Rate (2015-2020)
Figure 33. Mexico Gene Editing Revenue and Growth Rate (2015-2020)
Figure 34. Europe Gene Editing Revenue Market Share by Countries (2015-2020)
Figure 35. Europe Gene Editing Revenue Market Share by Countries in 2019
Figure 36. Germany Gene Editing Revenue and Growth Rate (2015-2020)
Figure 37. UK Gene Editing Revenue and Growth Rate (2015-2020)
Figure 38. France Gene Editing Revenue and Growth Rate (2015-2020)
Figure 39. Russia Gene Editing Revenue and Growth Rate (2015-2020)
Figure 40. Italy Gene Editing Revenue and Growth Rate (2015-2020)
Figure 41. Asia-Pacific Gene Editing Revenue Market Share by Countries (2015-2020)
Figure 42. Asia-Pacific Gene Editing Revenue Market Share by Countries in 2019
Figure 43. China Gene Editing Revenue and Growth Rate (2015-2020)
Figure 44. Japan Gene Editing Revenue and Growth Rate (2015-2020)
Figure 45. Korea Gene Editing Revenue and Growth Rate (2015-2020)
Figure 46. India Gene Editing Revenue and Growth Rate (2015-2020)
Figure 47. Southeast Asia Gene Editing Revenue and Growth Rate (2015-2020)
Figure 48. South America Gene Editing Revenue Market Share by Countries (2015-2020)
Figure 49. South America Gene Editing Revenue Market Share by Countries in 2019
Figure 50. Brazil Gene Editing Revenue and Growth Rate (2015-2020)
Figure 51. Argentina Gene Editing Revenue and Growth Rate (2015-2020)
Figure 52. Middle East and Africa Gene Editing Revenue Market Share by Countries (2015-2020)
Figure 53. Middle East and Africa Gene Editing Revenue Market Share by Countries in 2019
Figure 54. Saudi Arabia Gene Editing Revenue and Growth Rate (2015-2020)
Figure 55. UAE Gene Editing Revenue and Growth Rate (2015-2020)
Figure 56. Egypt Gene Editing Revenue and Growth Rate (2015-2020)
Figure 57. South Africa Gene Editing Revenue and Growth Rate (2015-2020)
Figure 58. Global Gene Editing Revenue Share by Type (2015-2020)
Figure 59. Global Gene Editing Revenue Share by Type in 2019
Figure 60. Global Gene Editing Market Share Forecast by Type (2021-2025)
Figure 61. Global Zinc finger nucleases (ZFNs) Revenue Growth Rate (2015-2020)
Figure 62. Global Transcription Activator-Like Effector-based Nucleases (TALENs) Revenue Growth Rate (2015-2020)
Figure 63. Global CRISPR-Cas system Revenue Growth Rate (2015-2020)
Figure 64. Global Gene Editing Revenue Share by Application (2015-2020)
Figure 65. Global Gene Editing Revenue Share by Application in 2019
Figure 66. Global Gene Editing Market Share Forecast by Application (2021-2025)
Figure 67. Global Biotechnology& Pharmaceutical Companies Revenue Growth Rate (2015-2020)
Figure 68. Global Academic& Government Research Institutes Revenue Growth Rate (2015-2020)
Figure 69. Global Contract Research Organizations Revenue Growth Rate (2015-2020)
Figure 70. Global Gene Editing Revenue (Million USD) and Growth Rate Forecast (2021-2025)
Figure 71. Global Gene Editing Revenue (Million USD) Forecast by Regions (2021-2025)
Figure 72. Global Gene Editing Revenue Market Share Forecast by Regions (2021-2025)
Figure 73. North America Gene Editing Revenue Market Forecast (2021-2025)
Figure 74. Europe Gene Editing Revenue Market Forecast (2021-2025)
Figure 75. Asia-Pacific Gene Editing Revenue Market Forecast (2021-2025)
Figure 76. South America Gene Editing Revenue Market Forecast (2021-2025)
Figure 77. Middle East and Africa Gene Editing Revenue Market Forecast (2021-2025)
Figure 78. Sales Channel: Direct Channel vs Indirect Channel
